Member Info for VincentVega

Good to hear from you neilin and thank you for your analysis.

Thanks for the update Hogbog.

Cue the usual ramper(s) that claim to sell out at price z but sell out from under you at y.

They’ve been easy to spot so far.

Good luck all LTH’s and newbies alike.

VV

Although I think that one of his colleagues hosted that one.

I’m currently travelling, so if anyone has the time I suppose a quick google of “ the Sunday roast Cizzle biotechnology” might garner some results.

VV

Charles Archer, amongst other things, is one of a handful of analysts that host The Sunday Roast. My fellow long term holders will remember AS appearing on this show via telephone (aka podcast) many moons ago. From memory, the last one was circa 2023.

Hope this helps.

@uncle, what’s your source?

VV

Also debuting…

https://www.theguardian.com/science/2026/may/30/cancer-jab-can-eradicate-entire-tumours-in-patients-trial-shows#img-1

On another note, a friend of mine visited the same site.

He was cleared for lung cancer but the scan picked up an aneurysm. He’s since had heart surgery and is now back on the golf course.

I’d hazard to guess how many lives such initiatives have saved.

Now if only…

I too took part in that initiative.

Mine took place in a Tesco car park in Cheshire.

Thankfully, all clear.

@Theonlywayis

It’s called hopium.

It also represents a 233% increase on the day of the RNS.

If you wet your finger and put it in the prevailing wind, you can come up with any number.

Backing it up is a whole other matter and they never do.

I’ve linked at least one.

@ thinshins.

If you think it’s rocketville on here it pales into insignificance with the idiots over on ADVFN.

It’s 5th of November and 4th July all rolled into one.

Had you levelled your post at a different individual that infests this board with his “guff”, I’d have ticked you up.

Having read the posts on here for as long as you have, like most LTH’s, we know who I’m talking about and It certainly isn’t Bermondsey.

More so given that our largest shareholder/funder seems to be a keeper.

That’s not to say he won’t sell a few down the line to reduce exposure or take some off the table to crystallise some gains, but much rather him than some death spiral funding arrangement that so many small companies have no other choice to sign up to to stay afloat or fund future growth.

I think we’re lucky to have FL on board.

“20p post news”

That’s an 8 bagger. You must be expecting a hell of a lot more progress in the next news release than I am.

Whilst PR is never a bad thing and I welcome the efforts in the US in this regard, it is only cold hard progress on the launch which is now more than 12mths late that will float my boat.

With regard to the UK, I’m not expecting any Earth-shattering news on progress, more of a “we are in discussions” type update.

Remember, the US launch was seen as a massive shortcut to get the product into the market and we’ve already spent 2 years to get to this point.

I hope I’m wrong, but I fail to see how the UK launch can be expedited in anywhere near the same timeframes as that of the US given the more stringent path to licensing.

I’d love to be proved totally wrong, but the pragmatist in me says otherwise if I use our US experience as the yardstick.

VV

If the same rule follows the reporting of large share transactions, then Lang will have 3 business days to declare the conversion of the loan notes.

IF he converts.

VV

Does everyone else find using a mobile phone to read messages or post a comment to be a complete nightmare on this site?

I’ve resorted to using my notes function and copy and pasting it into the message body.

VV

I must say, I think that in the whole, I agree with a lot of tech’s points, particularly the more cautionary contributions.

However, I feel that CLIA accreditation is such a massive milestone as well as a price sensitive piece in the jigsaw that they surely must be duty bound to announce it through the appropriate channel’s even in the UK. (RNS)

Much the same can be expected when Ciz Bio are awarded their reimbursement codes, unless I’ve missed a trick and these are issued as part of the accreditation.

Sorry for labouring the point but I do still feel that AS has a responsibility to seek out and deliver the maximum PR that he can muster over on this side of the pond.

I became envious of the sort of news items that were thrown our way regarding various cancer tests featured on Sky News and the BBC news channels.

That should be his bare minimum starting point.

Effect.

Oops

It’s great to see that the US is nearly there with the rollout.(finally!)

AS needs to take maximum advantage of PR on this side of the pond when the US launch is announced in order to apply a FOMO affect on the UK.

A failure to do so would be a gross dereliction on his part.

Excerpt from a post I made in July 24…

There are too many variables that exist at present to determine the sp trajectory. Test price being chief among them. 

I also believe that comparing OBDs rise is a moot point. After gaining the relevant compensation code, Jim Burrows stated in a presentation that demand for the test was unprecedented/exponential, or words to that effect. Statements such as this, along with retail fomo created a massive false flag rise in the SP. 

I tuned in to the results webinar some time ago when the truth regarding test uptake was laid bare. It wasn’t pretty viewing. 

I remember posting on here not long after that webinar that OBD was a minimum of 6mths behind the curve in getting its sales and marketing strategy in place and there’s still no evidence to suggest that they’ve gained the necessary traction to cover its massive ongoing cash burn, hence the miserable fall from Grace. 

Of course, CIZ doesn’t suffer such ongoing direct costs due to the licensing model, but the flip side is lower revenue per test in the form of royalty payments. 

One would hope that the Mgt team at Cizzle Inc can adequately put the horse in place before they hitch up the cart.